Shilajit D Kundu, MD
Chief of Urologic Oncology in the Department of Urology
Associate Professor of Urology
Focus of Work
Bio
Dr. Kundu has successfully conducted and published on prospective evaluations of patients with urologic cancers including prostate, bladder, kidney and testicular cancer and have found that the impact of cancer treatment goes beyond physical limitations associated with treatment. His recent research aims to understand the complexities associated with patient expectations. This includes balancing factors associated with patient satisfaction including patient personality, physician-patient relatio...[Read full text]
Academic Focus
Novel strategies to diagnose and characterize bladder cancer, novel strategies to characterized prostate cancer agressiveness, and prospectively studying quality of life outcomes in patients with urologic cancers
Clinical Focus
Treatment of bladder cancer, continent urinary diversions for bladder cancer, multimodal therapy for advanced cancers including surgical therapy for bladder cancer, prostate cancer, kidney cancer, testis cancer, robotic surgery for bladder cancer, and testis cancer treatment
Keywords
Select a keyword to see all related Feinberg faculty via the main faculty profile site.
Bladder CancerKidney Cancer / Urinary Tract CancerProstate CancerRobotic ProstatectomyRobotic NephrectomyCancer Genetics
Education and Certification
- MD: University of Illinois - Chicago (2001)
- Residency: Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) (2007)
- Fellowship: Memorial Sloan-Kettering Cancer Center (2009)
- Board Certification: Urology
Contact
Clinic (for patients): 312-695-8146
NMH/Galter Room 20-150
675 N Saint Clair
Chicago IL 60611